Cleveland Clinic physicians and scientists may collaborate with
the pharmaceutical or medical device industries to help develop
medical breakthroughs or provide medical expertise or education.
Cleveland Clinic strives to make scientific advances that will benefit
patient care and support outside relationships that promise public
benefit. In order for the discoveries of Cleveland Clinic physicians'
and scientists' laboratories and investigations to benefit the public,
these discoveries must be commercialized in partnership with industry.
As experts in their fields, Cleveland Clinic physicians and scientists
are often sought after by industry to consult, provide expertise and
education.
To assure professional and commercial integrity in such matters,
Cleveland Clinic maintains a program that reviews these collaborations
and, when appropriate, puts measures in place to minimize bias that may
result from ties to industry. The Cleveland Clinic publicly discloses
the names of companies when (i) its physicians/scientists receive $5,000
or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists
serve as a fiduciary, (iii) its physicians/scientists receive or have the
right to receive royalties or (iv) its physicians/ scientists hold any
equity interest for the physician's/scientist's role as inventor,
discoverer, developer, founder or consultant.* In publicly disclosing this
information, the Cleveland Clinic tries to provide information as accurately
as possible about its physicians' and scientists' connections with industry.
As of 3/29/2010, Dr. Singh has reported the financial relationships with the
companies listed below. In general, patients should feel free to contact
their doctor about any of the relationships and how the relationships are
overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's
policies on collaborations with industry and innovation management, go to our
Integrity in Innovation
page.
Consulting and/or Speaking. Dr. Singh receives fees of $5,000 or more per year as a paid consultant, speaker or member of an advirsory committee for the following companies:
Equity. Dr. Singh owns stock or stock options in the following companies for activities as a founder, inventor, discover, developer:
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.
